|
Oct 31
|
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference
|
|
Aug 23
|
Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
|
|
Aug 21
|
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
|